HeatSync Biochemistry Laboratory, Mesa, AZ, USA.
Neurology and Neurophysiology Center, Vienna, Austria.
Ann Afr Med. 2024 Jul 1;23(3):512-513. doi: 10.4103/aam.aam_32_23. Epub 2024 Jul 20.
Hyperkinesias in a patient with complex-I deficiency due to the variant m.10191T>C in MT-ND3 have not been previously reported. The patient is a 32 years-old female with multisystem mitochondrial disease due to variant m.10191T>C in MT-ND3, who has been experiencing episodic, spontaneous or induced abnormal movements since age 23. The abnormal movements started as right hemi-athetosis, bilateral dystonia of the legs, or unilateral dystonia of the right arm and leg. They often progressed to severe ballism, involving the trunk, and limbs. The arms were more dystonic than the legs. In conclusion, complex-I deficiency due to the variant m.10191T>C in MT-ND3 may manifest as multisystem disease including hyperkinesias. Neurologists should be aware of hyperkinesias as a manifestation of complex-I deficiency.
此前尚未有报道称,因 MT-ND3 中的变异 m.10191T>C 导致的复合体 I 缺陷会引起患者出现运动障碍。该患者为一名 32 岁女性,患有多系统线粒体疾病,病因是 MT-ND3 中的变异 m.10191T>C,自 23 岁起,她开始出现间歇性、自发性或诱发性异常运动。异常运动最初表现为右侧半身舞蹈徐动症、双侧腿部肌张力障碍,或单侧右臂和腿部的肌张力障碍。这些运动常进展为严重的舞蹈手足徐动症,累及躯干和四肢。上肢比下肢更具张力障碍。总之,因 MT-ND3 中的变异 m.10191T>C 导致的复合体 I 缺陷可能表现为包括运动障碍在内的多系统疾病。神经科医生应意识到运动障碍是复合体 I 缺陷的一种表现。